Published in Diabetes Care on December 01, 2013
Inverse association between diabetes and altitude: a cross-sectional study in the adult population of the United States. Obesity (Silver Spring) (2014) 0.95
Adipose tissue dysfunction and impaired metabolic health in human obesity: a matter of oxygen? Front Endocrinol (Lausanne) (2015) 0.94
Glucose homeostasis during short-term and prolonged exposure to high altitudes. Endocr Rev (2015) 0.90
Comment on Lecoultre et al. Ten nights of moderate hypoxia improves insulin sensitivity in obese humans. Diabetes care 2013;36:e197-e198. Diabetes Care (2014) 0.89
Calorie restriction in humans: An update. Ageing Res Rev (2016) 0.85
Effects of Hyperoxia on Oxygen-Related Inflammation with a Focus on Obesity. Oxid Med Cell Longev (2015) 0.79
PlanHab: the combined and separate effects of 16 days of bed rest and normobaric hypoxic confinement on circulating lipids and indices of insulin sensitivity in healthy men. J Appl Physiol (1985) (2016) 0.78
Hypoxia, Oxidative Stress and Fat. Biomolecules (2015) 0.77
Diet-induced weight loss decreases adipose tissue oxygen tension with parallel changes in adipose tissue phenotype and insulin sensitivity in overweight humans. Int J Obes (Lond) (2017) 0.75
A Molecular and Whole Body Insight of the Mechanisms Surrounding Glucose Disposal and Insulin Resistance with Hypoxic Treatment in Skeletal Muscle. J Diabetes Res (2016) 0.75
Response to comment on Lecoultre et al. Ten nights of moderate hypoxia improves insulin sensitivity in obese humans. Diabetes care 2013;36:e197-e198. Diabetes Care (2014) 0.75
Acute systemic insulin intolerance does not alter the response of the Akt/GSK-3 pathway to environmental hypoxia in human skeletal muscle. Eur J Appl Physiol (2015) 0.75
Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes (2008) 3.80
Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev (2013) 2.65
Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes (1995) 2.01
Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle. Diabetes (1995) 1.75
Stimulation of glucose transport in skeletal muscle by hypoxia. J Appl Physiol (1985) (1991) 1.67
Intermittent exercise with and without hypoxia improves insulin sensitivity in individuals with type 2 diabetes. J Clin Endocrinol Metab (2012) 1.13
Low prevalence of type 2 diabetes despite a high average body mass index in the Aymara natives from Chile. Nutrition (2001) 1.12
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med (2011) 8.00
Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med (2007) 3.92
A guide to analysis of mouse energy metabolism. Nat Methods (2011) 3.82
Increased food energy supply is more than sufficient to explain the US epidemic of obesity. Am J Clin Nutr (2009) 3.59
Is it time to change the way we report and discuss weight loss? Obesity (Silver Spring) (2009) 3.57
Estimating the changes in energy flux that characterize the rise in obesity prevalence. Am J Clin Nutr (2009) 3.56
Racial differences in abdominal depot-specific adiposity in white and African American adults. Am J Clin Nutr (2009) 3.39
Lateral hypothalamic area deep brain stimulation for refractory obesity: a pilot study with preliminary data on safety, body weight, and energy metabolism. J Neurosurg (2013) 3.31
Calorie restriction and aging: review of the literature and implications for studies in humans. Am J Clin Nutr (2003) 3.11
Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care (2006) 2.86
Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss. PLoS One (2009) 2.56
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol (2010) 2.50
The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring) (2010) 2.47
Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes (2005) 2.43
Validation study of energy expenditure and intake during calorie restriction using doubly labeled water and changes in body composition. Am J Clin Nutr (2007) 2.33
Effect of calorie restriction with or without exercise on body composition and fat distribution. J Clin Endocrinol Metab (2007) 2.33
Estimating the effects of energy imbalance on changes in body weight in children. Am J Clin Nutr (2006) 2.21
Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care (2012) 2.21
A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr (2006) 2.12
Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab (2012) 2.11
Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab (2006) 2.09
Effect of calorie restriction on resting metabolic rate and spontaneous physical activity. Obesity (Silver Spring) (2007) 2.06
Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab (2008) 2.02
Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S. Diabetes Care (2006) 1.96
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake. Cell Metab (2008) 1.94
Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy. J Gerontol A Biol Sci Med Sci (2010) 1.80
Self-report-based estimates of energy intake offer an inadequate basis for scientific conclusions. Am J Clin Nutr (2013) 1.79
Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS (2002) 1.79
Measurement of dietary restraint: validity tests of four questionnaires. Appetite (2006) 1.72
Adipose tissue collagen VI in obesity. J Clin Endocrinol Metab (2009) 1.70
Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting. Obes Res (2005) 1.69
Neuroimaging and obesity: mapping the brain responses to hunger and satiation in humans using positron emission tomography. Ann N Y Acad Sci (2002) 1.66
Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring) (2008) 1.64
The metabolic effects of lopinavir/ritonavir in HIV-negative men. AIDS (2004) 1.64
Low macrophage accumulation in skeletal muscle of obese type 2 diabetics and elderly subjects. Obesity (Silver Spring) (2012) 1.62
Isolation of human adipose-derived stem cells from biopsies and liposuction specimens. Methods Mol Biol (2008) 1.62
Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. Atherosclerosis (2008) 1.58
Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg (2009) 1.56
Muscle-associated triglyceride measured by computed tomography and magnetic resonance spectroscopy. Obesity (Silver Spring) (2006) 1.49
Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate. Diabetes (2008) 1.44
Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr (2005) 1.42
Caloric restriction in humans: impact on physiological, psychological, and behavioral outcomes. Antioxid Redox Signal (2010) 1.42
Metabolic slowing with massive weight loss despite preservation of fat-free mass. J Clin Endocrinol Metab (2012) 1.39
The role of mitochondria in health and disease. Curr Opin Pharmacol (2009) 1.37
Inactivation of PKCtheta leads to increased susceptibility to obesity and dietary insulin resistance in mice. Am J Physiol Endocrinol Metab (2006) 1.34
Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight. BMC Public Health (2007) 1.33
Physical activity level and physical functionality in nonagenarians compared to individuals aged 60-74 years. J Gerontol A Biol Sci Med Sci (2007) 1.29
Cytokine blockade attenuates sympathoexcitation in heart failure: cross-talk between nNOS, AT-1R and cytokines in the hypothalamic paraventricular nucleus. Eur J Heart Fail (2008) 1.28
Skeletal muscle mitochondria and aging: a review. J Aging Res (2012) 1.27
Sex differences in the human brain's response to hunger and satiation. Am J Clin Nutr (2002) 1.25
Assessing risk factors for obesity between childhood and adolescence: I. Birth weight, childhood adiposity, parental obesity, insulin, and leptin. Pediatrics (2002) 1.23
Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells. Stem Cells (2008) 1.23
Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes (2009) 1.23
Energy metabolism and oxidative stress: impact on the metabolic syndrome and the aging process. Endocrine (2006) 1.23
NOX activity is increased in mild cognitive impairment. Antioxid Redox Signal (2010) 1.22
Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. Obesity (Silver Spring) (2006) 1.21
Development of adherence metrics for caloric restriction interventions. Clin Trials (2011) 1.21
The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. J Clin Endocrinol Metab (2009) 1.20
Lower total adipocyte number but no evidence for small adipocyte depletion in patients with type 2 diabetes. Diabetes Care (2009) 1.19
Ethnic-specific BMI and waist circumference thresholds. Obesity (Silver Spring) (2011) 1.18
Adverse metabolic effects of dietary fructose: results from the recent epidemiological, clinical, and mechanistic studies. Curr Opin Lipidol (2013) 1.17
Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab (2007) 1.16
HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging. Aging Cell (2010) 1.16
Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers. Clin Infect Dis (2006) 1.15
Calorie restriction and bone health in young, overweight individuals. Arch Intern Med (2008) 1.14
Assessing risk factors for obesity between childhood and adolescence: II. Energy metabolism and physical activity. Pediatrics (2002) 1.14
Effect of caloric restriction in non-obese humans on physiological, psychological and behavioral outcomes. Physiol Behav (2008) 1.13
Approaches for quantifying energy intake and %calorie restriction during calorie restriction interventions in humans: the multicenter CALERIE study. Am J Physiol Endocrinol Metab (2011) 1.13
Microanalysis of eating behavior of three leptin deficient adults treated with leptin therapy. Appetite (2005) 1.10
Ectopic lipid accumulation and reduced glucose tolerance in elderly adults are accompanied by altered skeletal muscle mitochondrial activity. J Clin Endocrinol Metab (2011) 1.10
Aging, resting metabolic rate, and oxidative damage: results from the Louisiana Healthy Aging Study. J Gerontol A Biol Sci Med Sci (2007) 1.09
Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J Clin Endocrinol Metab (2012) 1.09
Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers. AIDS (2007) 1.07
Impaired insulin sensitivity and elevated ectopic fat in healthy obese vs. nonobese prepubertal children. Obesity (Silver Spring) (2011) 1.06
HIV protease inhibitors increase adiponectin levels in HIV-negative men. J Acquir Immune Defic Syndr (2004) 1.06
Trunk versus extremity adiposity and cardiometabolic risk factors in white and African American adults. Diabetes Care (2011) 1.06
Reduced oxygenation in human obese adipose tissue is associated with impaired insulin suppression of lipolysis. J Clin Endocrinol Metab (2010) 1.06
Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res (2002) 1.05
Habitual physical activity in children: the role of genes and the environment. Am J Clin Nutr (2005) 1.05
Inflammation and oxidative stress are elevated in the brain, blood, and adrenal glands during the progression of post-traumatic stress disorder in a predator exposure animal model. PLoS One (2013) 1.05
Physical activity in aging: comparison among young, aged, and nonagenarian individuals. J Appl Physiol (1985) (2008) 1.02
Weight gain reveals dramatic increases in skeletal muscle extracellular matrix remodeling. J Clin Endocrinol Metab (2014) 1.02
Empirical evaluation of the ability to learn a calorie counting system and estimate portion size and food intake. Br J Nutr (2007) 1.02
Caloric restriction with or without exercise: the fitness versus fatness debate. Med Sci Sports Exerc (2010) 1.02
Brown adipose tissue: mechanisms and potential therapeutic targets. Circulation (2012) 1.01
Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptin-deficient patients. J Clin Endocrinol Metab (2010) 1.01
Energy requirements in nonobese men and women: results from CALERIE. Am J Clin Nutr (2013) 1.01
Dynamic model predicting overweight, obesity, and extreme obesity prevalence trends. Obesity (Silver Spring) (2013) 1.01
The effect of caloric restriction interventions on growth hormone secretion in nonobese men and women. Aging Cell (2009) 1.00
Differential effect of weight loss on adipocyte size subfractions in patients with type 2 diabetes. Obesity (Silver Spring) (2009) 1.00
Energy restriction and aging. Curr Opin Clin Nutr Metab Care (2004) 1.00
Mitochondrial energetics and insulin resistance. Endocrinology (2008) 0.99
Regulation of skeletal muscle oxidative capacity and insulin signaling by the mitochondrial rhomboid protease PARL. Cell Metab (2010) 0.98
Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure. J Clin Endocrinol Metab (2010) 0.98
In vitro cellular adaptations of indicators of longevity in response to treatment with serum collected from humans on calorie restricted diets. PLoS One (2008) 0.97